Company UpdateNewspaper Publication
CommoditiesChemicals & PetrochemicalsCommodity Chemicals
Omkar Pharmachem Ltd
Showing the latest 10 filings. Sign in to filter or browse the full history.
10 of 24 filings·Updated 14 Aug 2026
Showing 10 of 24 filings.
14 Aug 20261 filing
13 Aug 20262 filings
ResultFinancial Results
Omkar Pharmachem Ltd: Standalone Q1 2026 unaudited results show net income ₹9.00 lakh, PAT ₹-1.00 lakh
Standalone unaudited results (quarter ended 30-06-2026)
- Board approved the unaudited results on 13 Aug 2026.
- Net Sales/Income from Operations: 0.00 Rs in lakh for quarter ended 30-06-2026.
- Other Operating Income: 9.00 Rs in lakh for quarter ended 30-06-2026.
- Net Total Income: 9.00 Rs in lakh for quarter ended 30-06-2026.
- Employee benefits expenses: 514 Rs in lakh.
- Depreciation and Amortization: 0.04 Rs in lakh.
- Other Expenses: 482 Rs in lakh.
- Total Expenses: 10.00 Rs in lakh.
- Profit before tax: -1.00 Rs in lakh.
- Tax expense: 0.00 Rs in lakh.
- Profit after tax: -1.00 Rs in lakh.
- Other Comprehensive Income (Expense): 0.00 Rs in lakh.
Board MeetingOutcome of Board Meeting
Omkar Pharmachem approves standalone unaudited Q1 2026 results with Limited Review Report
Financial results approved
- Standalone unaudited financial results for quarter ended 30 June 2026 approved with Limited Review Report.
18 Jul 20261 filing
Company UpdateGeneral
Omkar Pharmachem announces SEBI special window for transfer and demat of physical shares
Demat transfer window
- Special window opened for transfer and dematerialization of physical Omkar shares.
- Cites SEBI circular HO/38/13/11(2)2026-MIRSD-POD/1/3750/2026 dated Jan 30, 2026.
- Newspaper advertisements enclosed in Vernacular and English.
- Notice to BSE to record this information.
13 Jul 20262 filings
Company UpdateCertificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Regulation 74(5) certificate confirms dematerialisation processing and stock exchange listings.
Dematerialisation status
- Dematerialisation requests were processed and confirmed to the depositories.
- Securities dematerialised have been listed on the stock exchanges where the earlier issued securities are listed.
- Physical certificates for dematerialisation were mutilated and cancelled, with depository name substituted as registered owner within prescribed timeline.
Company UpdateCertificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate confirms dematerialisation processing, listing of securities, and registrar updates
Dematerialisation/Rematerialisation status
- Dematerialisation requests processed; securities confirmed to depositories.
- Securities in demat listed on the stock exchange(s) where earlier issues are listed.
- Physical certificates mutilated and cancelled after verification.
- Depository name substituted as registered owner in records within the time limit.
13 Apr 20261 filing
Company UpdateCertificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Dear Sir/Ma''am, Please find Certificate under Ref. 74 (5) of SEBI (DP) Regulations, 2018 for the quarter ended 31.03.2026.
25 Mar 20262 filings
Insider Trading / SASTClosure of Trading Window
Dear Sir, Pursuant to SEBI (LODR), 2015 as amended and in compliance with the terms of Code of Conduct of the company, please note that the Trading Window for dealing in the securitites ....
Company UpdateGeneral
Dear Sir/Ma''am, Please find Newspaper Publication regarding special window for transfer and dematerialization of physical shares.
12 Feb 20261 filing
Company UpdateGeneral
Dear Sir, Please find Report on action taken under the Special Window for re-lodgement of transfer request from 01.01.2026 to 06.01.2026
Showing 10 of 24 filings